November 5, 2018 09:12 AM EST
R&D

Eli Lil­ly touts MACE win for di­a­betes block­buster Trulic­i­ty — a 'nice pos­i­tive'

John Carroll

Editor & Founder

Eli Lil­ly $LLY is boast­ing about a big win for its block­buster di­a­betes drug Trulic­i­ty, say­ing their drug pro­duced “com­pelling” ev­i­dence of its abil­i­ty to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times